BACKGROUND: A proportion of patients with subcortical lacunes will suffer progressive cognitive dysfunction, but the basis for this decline is controversial and little is known about predicting cognitive decline in these patients. Studies of Alzheimer disease have shown that imaging measures of temporal and parietal metabolism and blood flow predict disease course. OBJECTIVE: To determine whether regional cerebral glucose metabolism predicts cognitive decline by testing 2 opposing hypotheses: (1) temporoparietal activity predicts decline (based on the idea that concomitant Alzheimer disease causes decline) vs (2) frontal hypometabolism predicts decline (based on evidence that subcortical frontal circuits are especially vulnerable to small vessel ischemia). DESIGN: Prospective cohort study. SETTING: University outpatient dementia center. PATIENTS: A convenience sample of 26 patients with radiologically defined lacunes and baseline cognitive function ranging from normal to moderately demented. MAIN OUTCOME MEASURES: Regional cerebral metabolism was quantitated in the form of atrophy-corrected positron emission tomographic activity ratios in cortical regions that were defined a priori. Patients were followed up at a mean of 1.8 years, and the dependent variable was rate of change in the Mini-Mental State Examination score. RESULTS: Bilateral and right hemisphere dorsolateral frontal metabolism significantly predicted cognitive decline, with right dorsolateral frontal metabolism explaining 19% of the variance. No other positron emission tomographic region was a significant predictor, nor were demographic variables or baseline Mini-Mental State Examination scores significant predictors. CONCLUSION: Cognitive decline in patients with lacunes may result in part from progressive vascular compromise in subcortical frontal circuits.
BACKGROUND: A proportion of patients with subcortical lacunes will suffer progressive cognitive dysfunction, but the basis for this decline is controversial and little is known about predicting cognitive decline in these patients. Studies of Alzheimer disease have shown that imaging measures of temporal and parietal metabolism and blood flow predict disease course. OBJECTIVE: To determine whether regional cerebral glucose metabolism predicts cognitive decline by testing 2 opposing hypotheses: (1) temporoparietal activity predicts decline (based on the idea that concomitant Alzheimer disease causes decline) vs (2) frontal hypometabolism predicts decline (based on evidence that subcortical frontal circuits are especially vulnerable to small vessel ischemia). DESIGN: Prospective cohort study. SETTING: University outpatientdementia center. PATIENTS: A convenience sample of 26 patients with radiologically defined lacunes and baseline cognitive function ranging from normal to moderately demented. MAIN OUTCOME MEASURES: Regional cerebral metabolism was quantitated in the form of atrophy-corrected positron emission tomographic activity ratios in cortical regions that were defined a priori. Patients were followed up at a mean of 1.8 years, and the dependent variable was rate of change in the Mini-Mental State Examination score. RESULTS: Bilateral and right hemisphere dorsolateral frontal metabolism significantly predicted cognitive decline, with right dorsolateral frontal metabolism explaining 19% of the variance. No other positron emission tomographic region was a significant predictor, nor were demographic variables or baseline Mini-Mental State Examination scores significant predictors. CONCLUSION:Cognitive decline in patients with lacunes may result in part from progressive vascular compromise in subcortical frontal circuits.
Authors: Nan Wang; Gilles Allali; Chandrasekharan Kesavadas; Mohan L Noone; Vayyattu G Pradeep; Helena M Blumen; Joe Verghese Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Catherine L Carey; Joel H Kramer; S Andrew Josephson; Dan Mungas; Bruce R Reed; Norbert Schuff; Michael W Weiner; Helena C Chui Journal: Stroke Date: 2007-12-20 Impact factor: 7.914
Authors: Thaddeus J Haight; Susan M Landau; Owen Carmichael; Christopher Schwarz; Charles DeCarli; William J Jagust Journal: JAMA Neurol Date: 2013-08 Impact factor: 18.302
Authors: Norbert Schuff; Shinji Matsumoto; Joseph Kmiecik; Colin Studholme; Antao Du; Frank Ezekiel; Bruce L Miller; Joel H Kramer; William J Jagust; Helen C Chui; Michael W Weiner Journal: Alzheimers Dement Date: 2009-11 Impact factor: 21.566
Authors: Panteleimon Giannakopoulos; Enikö Kövari; François R Herrmann; Patrick R Hof; Constantin Bouras Journal: Stroke Date: 2008-12-31 Impact factor: 7.914
Authors: Deborah A Cahn-Weiner; Sarah Tomaszewski Farias; Laura Julian; Danielle J Harvey; Joel H Kramer; Bruce R Reed; Dan Mungas; Margaret Wetzel; Helena Chui Journal: J Int Neuropsychol Soc Date: 2007-05-18 Impact factor: 2.892